Found: 26
Select item for more details and to access through your institution.
Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 16, p. 1179, doi. 10.1093/jnci/djn233
- By:
- Publication type:
- Article
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 389, doi. 10.1007/s10549-023-06910-6
- By:
- Publication type:
- Article
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 2, p. 561, doi. 10.1007/s10549-020-06016-3
- By:
- Publication type:
- Article
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 1, p. 95, doi. 10.1007/s10549-018-05088-6
- By:
- Publication type:
- Article
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 2, p. 371, doi. 10.1007/s10549-018-4792-0
- By:
- Publication type:
- Article
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 121, doi. 10.1007/s10549-018-4811-1
- By:
- Publication type:
- Article
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 1, p. 179, doi. 10.1007/s10549-017-4415-1
- By:
- Publication type:
- Article
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Extended Endocrine Therapy for Early-Stage Breast Cancer: How Do We Decide?
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 12, p. N.PAG, doi. 10.1007/s11912-020-00988-7
- By:
- Publication type:
- Article
Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 2, p. 317, doi. 10.1007/s10147-014-0712-4
- By:
- Publication type:
- Article
Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 19, p. 6954, doi. 10.1002/cam4.3358
- By:
- Publication type:
- Article
State of Personalized Medicine in Breast Cancer.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2016, v. 7, p. 44
- By:
- Publication type:
- Article
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
- Published in:
- Journal of Cancer Survivorship, 2022, v. 16, n. 3, p. 542, doi. 10.1007/s11764-021-01049-z
- By:
- Publication type:
- Article
Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.752689
- By:
- Publication type:
- Article
Obese Breast Cancer Patients and Survivors: Management Considerations.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 8, p. 410
- By:
- Publication type:
- Article
Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?
- Published in:
- Oncology (08909091), 2016, v. 30, n. 2, p. 148
- By:
- Publication type:
- Article
Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 11, p. 828
- By:
- Publication type:
- Article
The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor--Positive Early-Stage Breast Cancer... [including commentary by ANN H. PARTRIDGE].
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor--Positive Early-Stage Breast Cancer... [including commentary by ANN H. PARTRIDGE].
- Published in:
- Oncology (08909091), 2015, v. 29, n. 7, p. 473
- By:
- Publication type:
- Article
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapy.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 8, p. 6613, doi. 10.1007/s00520-022-07071-w
- By:
- Publication type:
- Article
UNA ALTA DIVERSIDAD DE HONGOS MICORRÍZICOS ARBUSCULARES INFLUYE EN LA ABSORCIÓN DE CADMIO Y CRECIMIENTO VEGETATIVO DEL CACAO.
- Published in:
- BIOAGRO, 2022, v. 34, n. 1, p. 75, doi. 10.51372/bioagro341.7
- By:
- Publication type:
- Article
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00500-3
- By:
- Publication type:
- Article
State of Personalized Medicine in Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 112
- By:
- Publication type:
- Article
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 3, p. 324, doi. 10.1016/j.clbc.2022.12.006
- By:
- Publication type:
- Article
Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.
- Published in:
- 2012
- By:
- Publication type:
- journal article